FOUR-WEEK INTRAVENOUS TOXICITY EVALUATION OF RECOMBINANT HUMAN ERYTHROPOIETIN, YHB216 IN BEAGLE DOGS

  • Sin, Ji-Soon (College of Veterinary Medicine, Chungbuk National University) ;
  • Jung, Eun-Yong (College of Veterinary Medicine, Chungbuk National University) ;
  • Zhang, Hu-Song (College of Veterinary Medicine, Chungbuk National University) ;
  • Huang, Zai-Zhi (College of Veterinary Medicine, Chungbuk National University) ;
  • Zheng, Mei-Shu (College of Veterinary Medicine, Chungbuk National University) ;
  • Kim, Dong-Kyu (College of Veterinary Medicine, Chungbuk National University) ;
  • Roh,Yong-Woo (College of Veterinary Medicine, Chungbuk National University) ;
  • Choi, Ehn-Kyung (College of Veterinary Medicine, Chungbuk National University) ;
  • Nam, Sang-Yoon (College of Veterinary Medicine, Chungbuk National University) ;
  • Kang, Jong-Koo (College of Veterinary Medicine, Chungbuk National University)
  • Published : 2001.10.01

Abstract

To investigate the safety and toxicity of a recombinant human erythropoietin, YHB216, we performed 4-week repeated dose toxicity test in 4-month-old Beagle dogs. We injected intravenously everyday for 28 days with dosages of 0, 500, 2,500 and 12,500 I.U/kg body weight. There were not observed clinical signs or motality in the animals treated with YHB216. There were no significant changes in body weight, feed, or water consumption.(omitted)

Keywords